Wheeling, WV (JK) – West Virginia University Health System has agreed to pay $4,177,139 to resolve federal civil allegations that it violated multiple provisions of the Controlled Substances Act between 2017 and 2024.
According to the U.S. Attorney’s Offices for the Northern and Southern Districts of West Virginia, a DEA investigation found the health system failed to report significant thefts or losses of controlled substances and committed numerous recordkeeping and administrative violations. Investigators also cited inaccurate inventory records, errors involving DEA order forms, and policies that did not fully comply with federal requirements.
In addition to the monetary settlement, WVU Health System has entered a three-year Memorandum of Agreement with the DEA. The agreement requires systemwide compliance improvements, including enhanced diversion oversight, faster reporting of thefts or losses, expanded employee training and auditing, and the installation of hundreds of security cameras where controlled substances are stored.
Comments